Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS) - 02/09/11
Abstract |
Objective: We attempted to determine the prevalence and predictors of skin disease in a cohort of women with and at risk for HIV infection. Methods: We analyzed baseline data from a multicenter longitudinal study of HIV infection in women. Results: A total of 2018 HIV-infected women and 557 HIV-uninfected women were included in this analysis. Skin abnormalities were reported more frequently among HIV-infected than uninfected women (63% vs 44%, respectively; odds ratio [OR] 2.10; 95% confidence interval [95% CI], 1.74-2.54). Infected women were also more likely to have more than 2 skin diagnoses (OR, 3.27; 95% CI, 1.31-8.16). Folliculitis, seborrheic dermatitis, herpes zoster, and onychomycosis were more common among HIV-infected women (P < .05). Independent predictors of abnormal findings on skin examination in the infected women were African American race (OR, 1.38; 95% CI, 1.07-1.77), injection drug use (OR, 2.74; 95% CI, 2.11-3.57), CD4+ count less than 50 (OR, 1.68; 95% CI, 1.17-2.42), and high viral loads (100,000-499,999 = OR, 1.77; 95% CI, 1.32-2.37; >499,999 = OR, 2.15; 95% CI, 1.42-3.27). Conclusion: HIV infection was associated with a greater number of skin abnormalities and with specific dermatologic diagnoses. Skin abnormalities were also more common among women with CD4+ cell depletion or higher viral load. (J Am Acad Dermatol 2001;44:785-8.)
Le texte complet de cet article est disponible en PDF.Plan
The WIHS is funded by the National Institute of Allergy and Infectious Diseases, with supplemental funding from the National Cancer Institute, the National Institute of Child Health & Human Development, The National Institute of Drug Abuse, the National Institute of Dental Research, the Agency for Health Care Policy and Research, and the Centers for Disease Control and Prevention. Grant numbers U01-AI-35004, U01-AI-31834, U01-AI-34994, U01-AI-34989, U01-HD-32632(NICHD), U01-AI-34993, U01-AI-42590, M01-RR00071, and M01-RR00083. |
|
Reprint requests: Paradi Mirmirani, MD, University of California, San Francisco, 1701 Divisadero St, 3rd Floor, San Francisco, CA 94143-0316. |
|
J Am Acad Dermatol 2001;44:785-8 |
Vol 44 - N° 5
P. 785-788 - mai 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?